Archive for March, 2015

In Guiding Initial Dosing Of Common Blood Thinner, Genetic Testing Not Cost-Effective

Sickle Cell Treatment Developed At LA BioMed Enters Phase 3 Clinical Trial

Diagnosis And Treatment Of Inflammatory Bowel Disease Should Improve Following Discovery Of Genetic Defect

Study Analysis Shows That Eltrombopag Significantly Improves Platelet Count And Response Rates In Idiopathic Thrombocytopenic Purpura (ITP)

First Structure Of A Class Of Proteins That Help Guide Blood Cell Movement Revealed: Findings May Lead To New Drugs For Cancer, Immune Disorders Aids

ThermoGenesis Corp. Signs Agreement With Biomet Biologics, Inc. To Produce Intra-Operative Autologous Fibrin Sealant

For The Latest In Hematology See New Edition Of Medical Reference Book

Randox Introduces A Range Of 25 Liquid And Ready-To-Use Protein Assays

FDA Approves Voluven To Treat Serious Blood Volume Loss During And After Surgery

Mutant Rats Resist Warfarin

Tag Cloud